In Preclinical Model of Ovarian Cancer, the SGK1 Inhibitor SI113 Counteracts the Development of Paclitaxel Resistance and Restores Drug Sensitivity.
D'Antona L, Dattilo V, Catalogna G, Scumaci D, Fiumara CV, Musumeci F, Perrotti G, Schenone S, Tallerico R, Spoleti CB, Costa N, Iuliano R, Cuda G, Amato R, Perrotti N.
D'Antona L, et al. Among authors: schenone s.
Transl Oncol. 2019 Aug;12(8):1045-1055. doi: 10.1016/j.tranon.2019.05.008. Epub 2019 Jun 1.
Transl Oncol. 2019.
PMID: 31163384
Free PMC article.